X
X

Mumbai Borivali

Home / Research & Trials / Mumbai Borivali

Mumbai Borivali
Sl.No Principal Investigator’s Name Study Title Phase Protocol Number Indications Department Study Status Link Contact Person & Contact Details
1 Dr Indoo Ammbulkar A Randomized, Open-Label, Phase 3 Study of LY3484356 vs Investigator’s Choice of Endocrine Therapy, in Patients with Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated with Endocrine Therapy Phase 3 LY2835219 Breast Cancer Department of Medical Oncology Ongoing NA Anu Koundal – 9899844877
2 Dr Indoo Ammbulkar A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center, International Study of Durvalumab Given Concurrently With Definitive Chemoradiation Therapy in Patients With Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma (KUNLUN) Phase 3 D910SC00001 Esophageal Squamous Cell Carcinoma Department of Medical Oncology Initial stage https://clinicaltrials.gov/ct2/show/NCT04550260 Shilpa Daniel – 9953233963
3 Dr Indoo Ammbulkar A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd followed by THP Compared to ddAC-THP in Participants with High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11) Phase 3 D967RC00001 Breast Cancer Department of Medical Oncology Initial stage https://clinicaltrials.gov/ct2/show/NCT05113251 Ankita Solanki – 9820225226

To get in touch with the Clinical Trials Team at HCG, please call on +91 80 4020 6000 (extn: 6058)

Research and Trials

To know more about facilities available for patients at HCG

HCG Call Icon